This report contains market size and forecasts of Neratinib in global, including the following market information:
Global Neratinib Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Neratinib Market Sales, 2017-2022, 2023-2028, (K Pcs)
Global top five Neratinib companies in 2021 (%)
The global Neratinib market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
40mg/180 Tablets Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Neratinib include Puma Biotechnology and Beacon Pharmaceuticals Limited etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Neratinib manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Neratinib Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Neratinib Market Segment Percentages, by Type, 2021 (%)
40mg/180 Tablets
40mg/150 Tablets
40mg/90 Tablets
Global Neratinib Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Neratinib Market Segment Percentages, by Application, 2021 (%)
Early Breast Cancer
Other
Global Neratinib Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Neratinib Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Neratinib revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Neratinib revenues share in global market, 2021 (%)
Key companies Neratinib sales in global market, 2017-2022 (Estimated), (K Pcs)
Key companies Neratinib sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Puma Biotechnology
Beacon Pharmaceuticals Limited